NHS Framework Agreement for Aflibercept injection and Ranibizumab injection
Awarded by NHS England · 2018-07-03T14:51:04+01:00 · £1,220,000,000
Description
NHS Framework Agreement for Proprietary Pharmaceuticals - Afliercept and Ranibizumab ophthalmology products Offer reference number: CM/PHR/17/5561 Period of framework agreement: 1 August 2018 - 31 July 2020 (at the Authority's discretion) for a period or periods up to a total of 24 months
- Buyer
- NHS England
- Value
- £1,220,000,000
- Category (CPV)
- Pharmaceutical products
- Award date
- 2018-07-03T14:51:04+01:00
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.